Literature DB >> 12525724

The impact of comorbid disease and injuries on resource use and expenditures in parkinsonism.

J C Pressley1, E D Louis, M-X Tang, L Cote, P D Cohen, S Glied, R Mayeux.   

Abstract

BACKGROUND: Persons with parkinsonism have high rates of both associated and unrelated prevalent comorbid conditions. A better understanding of patterns of care and expenditures may aid in designing programs to enhance functioning, lengthen independent living, and manage costs.
METHODS: The authors linked national survey data of 24,831 elderly to nearly 1.9 million Medicare claims. Persons with parkinsonism (n = 791) were identified from survey or Medicare encounters for paralysis agitans. Comorbid disease risk was measured using age-adjusted OR with 95% CI. Comorbidity cost ratios (ratio of average per person per year charges for parkinsonism alone vs with comorbid conditions) were developed to describe incremental costs of comorbidities.
RESULTS: Patients with parkinsonism were older (78.5 +/- 7.6 vs 75.1 +/- 8.3 years, p < 0.0001) and had more injuries resulting in broken bones (35.6% vs 19.5%, p < 0.0001), including broken hips (15.9% vs 5.8%, p < 0.0001), during the 5-year study. Broken hips were more prevalent among men (OR 3.4, 95% CI 2.5 to 4.8) and women (OR 2.5, 95% CI 2.1 to 3.1) with than without parkinsonism. Among those with parkinsonism, comorbidity cost ratios demonstrated two- to threefold higher charges for dementia, broken bones, broken hip, and diabetes.
CONCLUSIONS: Comorbidity associated with parkinsonism is an under-recognized contribution to higher resource use and expenditures. Further study of injuries, dementia, and diabetes is required to assess whether public health interventions could reduce excess morbidity and expenditures associated with parkinsonism.

Entities:  

Mesh:

Year:  2003        PMID: 12525724     DOI: 10.1212/wnl.60.1.87

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  51 in total

1.  Effects of unilateral nigrostriatal dopamine depletion on peripheral glucose tolerance and insulin signaling in middle aged rats.

Authors:  J K Morris; N B Seim; G L Bomhoff; P C Geiger; J A Stanford
Journal:  Neurosci Lett       Date:  2011-09-21       Impact factor: 3.046

2.  Functional gait assessment and balance evaluation system test: reliability, validity, sensitivity, and specificity for identifying individuals with Parkinson disease who fall.

Authors:  Abigail L Leddy; Beth E Crowner; Gammon M Earhart
Journal:  Phys Ther       Date:  2010-11-11

3.  Residual sympathetic tone is associated with reduced insulin sensitivity in patients with autonomic failure.

Authors:  Jorge E Celedonio; Amy C Arnold; William D Dupont; Claudia E Ramirez; André Diedrich; Luis E Okamoto; Satish R Raj; David Robertson; Amanda C Peltier; Italo Biaggioni; Cyndya A Shibao
Journal:  Clin Auton Res       Date:  2015-09-10       Impact factor: 4.435

4.  Minority enrollment in Parkinson's disease clinical trials.

Authors:  Myra G Schneider; Christopher J Swearingen; Lisa M Shulman; Jian Ye; Mona Baumgarten; Barbara C Tilley
Journal:  Parkinsonism Relat Disord       Date:  2008-08-09       Impact factor: 4.891

Review 5.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

6.  Measures of striatal insulin resistance in a 6-hydroxydopamine model of Parkinson's disease.

Authors:  J K Morris; H Zhang; A A Gupte; G L Bomhoff; J A Stanford; P C Geiger
Journal:  Brain Res       Date:  2008-09-11       Impact factor: 3.252

7.  Gait function and locus coeruleus Lewy body pathology in 51 Parkinson's disease patients.

Authors:  Kelly A Mills; Zoltan Mari; Catherine Bakker; Vanessa Johnson; Gregory M Pontone; Alexander Pantelyat; Juan C Troncoso; Olga Pletnikova; Ted M Dawson; Liana S Rosenthal
Journal:  Parkinsonism Relat Disord       Date:  2016-09-25       Impact factor: 4.891

Review 8.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

Review 9.  Postural instability in patients with Parkinson's disease. Epidemiology, pathophysiology and management.

Authors:  Samuel D Kim; Natalie E Allen; Colleen G Canning; Victor S C Fung
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

10.  Co-occurring chronic conditions and healthcare expenditures associated with Parkinson's disease: a propensity score matched analysis.

Authors:  Sandipan Bhattacharjee; Usha Sambamoorthi
Journal:  Parkinsonism Relat Disord       Date:  2013-05-13       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.